Mechanistic investigations suggest that overexpression of GALNT1 in GC cells modifies the O-glycosylation of CD44, stimulating the Wnt/β-catenin signaling pathway to promote the progression and metastasis of GC. The gene discussed is GALNT1; the disease is gastric cancer.